CASE STUDY
September 28, 2022
A Big Rescue for a Study with the Tiniest of Patients
Learn more about one of PharPoint’s recent success stories in this Phase 1, neonatal cardiovascular rescue.
PharPoint’s experts work as an extension of your team to strategically plan, execute, and analyze Phase 1 – Phase 4 clinical trials. For more information about PharPoint’s services and expertise, reach out to our business development team.
RELATED RESOURCES
Exploring Standard CRO Timeline Benchmarks
Preparing to work with a top biometrics contract research organization and wondering how their promised data management, biostatistics, and medical writing timelines match up to the industry average? To help sponsors dig into these details and ensure the timelines they’re receiving are competitive, we’re providing PharPoint’s typical timelines alongside research that calculates industry standard timelines, when available.
Our hope is that this document can help sponsors set realistic expectations, confidently ask the right questions of their vendors, and ultimately, partner with a top biometrics CRO that keeps their study moving: because patients are waiting.
eBook contents include:
PharPoint’s short eBook, Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs, includes the below information.
- Standard database build timeline
- The bigger picture: Considering site identification and study start-up
- Standard mid-study database change timeline
- Standard database lock time
- Six strategies for a faster database lock
- Evaluating database lock to top line results timeline
- Ensuring a rapid delivery
- Evaluating database lock to delivery of tables, listings, and figures (TLF) timeline
- Standard clinical study report delivery timeline
- About PharPoint Research
Compare Standard Clinical Trial Timelines
For instant access to the eBook, fill out the form below.
RELATED RESOURCES